Orchard Therapeutics (ORTX) PT Lowered to $15 at Wedbush, Following Earnings

August 6, 2020 2:06 PM EDT
Get Alerts ORTX Hot Sheet
Price: $2.87 +0.70%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten lowered the price target on Orchard Therapeutics (NASDAQ: ORTX) to $15.00 (from $20.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Earnings